| 注册
首页|期刊导航|中国药理学通报|小鼠骨髓来源巨噬细胞的SILAC代谢标记及生物质谱分析

小鼠骨髓来源巨噬细胞的SILAC代谢标记及生物质谱分析

王通 郭嘉慧 陈智鹏 银兴峰 马文心 崔毅峙

中国药理学通报2012,Vol.28Issue(6):881-884,4.
中国药理学通报2012,Vol.28Issue(6):881-884,4.DOI:10.3969/j.issn.1001-1978.2012.06.033

小鼠骨髓来源巨噬细胞的SILAC代谢标记及生物质谱分析

SILAC labeling of mouse bone marrow-derived macrophage and mass spectrometry

王通 1郭嘉慧 1陈智鹏 1银兴峰 1马文心 1崔毅峙1

作者信息

  • 1. 暨南大学生命与健康工程研究院,广东,广州,510632
  • 折叠

摘要

Abstract

Aim Mouse bone marrow-derived macrophages (BMM) are recognized as standard model cells of macrophages, thus serving as a key tool and objective cell type in pharmacology. Due to limited proliferation capacity of macrophages, meta-bolically labeling BMM remains as a challenge in macrophage biological investigations. Therefore, the focus of this study was to label BMM with stable isotope labeling with amino acids in cell culture (SILAC). Methods Methods include: mouse bone marrow isolation, 6-day differentiation with M-CSF to prepare BMM; meanwhile, to use SILAC to label global proteins, followed by cell lysis, SDS-PAGE separation, in-gel digestion, mass spectrometry and bioinformatics. Results On Day 6 post-differentiation, 96. 5% of total mouse bone marrow cells wereobserved to become mature BMM. 70 ku band in SDS-PAGE separation was adopted to test the labeling efficiencies. The number of heavy lysine labeled proteins were 18, 12 and 13 for the time points of Day 6, 8 10 post-differentiation. Eight proteins were repeatedly identified in all time points. Statistically, the labeling efficiencies of the three time points were (90. 62 ± 0. 03)% , (90. 23 ±0. 03)% and (90. 40 ± 0. 02)% , respectively. Conclusion These results ensure the feasibility of employing SILAC-based proteomics in macrophage-relevant pharmacological investigations.

关键词

小鼠骨髓来源巨噬细胞(BMM)/SILAC/质谱/标记效率/蛋白质组/定量

Key words

bone marrow-derived macrophage (BMM)/SILAC/ mass spectrometry/ labeling efficiency/ proteome/ quantification

分类

医药卫生

引用本文复制引用

王通,郭嘉慧,陈智鹏,银兴峰,马文心,崔毅峙..小鼠骨髓来源巨噬细胞的SILAC代谢标记及生物质谱分析[J].中国药理学通报,2012,28(6):881-884,4.

基金项目

国家自然科学基金资助项目(No 81000516) (No 81000516)

国家重点基础研究发展计划(973计划)项目(No 2011CB910701) (973计划)

教育部博士点基金项目(No 20104401120008) (No 20104401120008)

暨南大学优秀本科推免研究生科研创新培育计划项目(No 50503590) (No 50503590)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文